Editas Medicine (NASDAQ:EDIT) shareholders have endured a 87% loss from investing in the stock three years ago
Editas Medicine, Inc. (NASDAQ:EDIT) shareholders should be happy to see the share price up 24% in the last quarter. But the last three years have seen a terrible decline. In that time the share price ...